JOHNSON & JOHNSON

Trading Ideas Johnson & Johnson Kazakhstan S.E.

Equities

JNJ_KZ

US4781601046

End-of-day quote Kazakhstan S.E. Other stock markets 03:30:00 28/06/2024 am IST			5-day change	1st Jan Change
149.6 ^USD	+1.39%		-0.01%	-4.98%

01/07	New semester, new state of mind
28/06	Johnson & Johnson Reports 'Positive' Results in Late-Stage Myasthenia Gravis Trial	MT

Trading Ideas

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

JOHNSON & JOHNSON :An end to the technical rebound lies ahead	27/19/27
JOHNSON & JOHNSON :The underlying trend is to the upside	12/17/12
JOHNSON & JOHNSON :Expect the comeback of a strong trend	10/17/10
JOHNSON & JOHNSON :Buying pressure	22/16/22
JOHNSON & JOHNSON :A good level to buy	12/16/12
JOHNSON & JOHNSON :Towards historic highs	26/12/26
JOHNSON & JOHNSON :Beginning of a bearish movement	26/12/26

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

Joseph Wolk, CFO of J&J: End of patent for its flagship drug

Joseph Wolk, CFO of J&J: End of patent for its flagship drug

January 23, 2024 at 11:00 pm IST

Secure and Increase the Performance of your Investments with our Team of Experts at your Side

Securing my Investments

fermer